BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3287428)

  • 21. Analysis of cell survival after multiple fractions per day and low-dose-rate irradiation of two in vitro cultured rat tumor cell lines.
    van Rongen E
    Radiat Res; 1985 Oct; 104(1):28-46. PubMed ID: 4048393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prediction of tumor treatment response to radiotherapy].
    Sasaki T
    Gan No Rinsho; 1989 Oct; 35(13):1487-93. PubMed ID: 2685388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
    Malaise EP; Lambin P; Joiner MC
    Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A benchmark of cell survival models using survival curves for human cells after completion of repair of potentially lethal damage.
    Fertil B; Reydellet I; Deschavanne PJ
    Radiat Res; 1994 Apr; 138(1):61-9. PubMed ID: 8146301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters.
    Eastham AM; Marples B; Kiltie AE; Orton CJ; West CM
    Br J Cancer; 1999 Mar; 79(9-10):1366-71. PubMed ID: 10188877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves.
    Fertil B; Dertinger H; Courdi A; Malaise EP
    Radiat Res; 1984 Jul; 99(1):73-84. PubMed ID: 6739728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity.
    Wouters BG; Sy AM; Skarsgard LD
    Radiat Res; 1996 Oct; 146(4):399-413. PubMed ID: 8927712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
    Withers HR; Mason KA; Taylor JM; Kim DK; Smathers JB
    Radiat Res; 1993 Jun; 134(3):295-300. PubMed ID: 8316621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between cell survival and specific energy spectra for therapeutic alpha-particle emitters.
    Roeske JC; Stinchcomb TG
    Radiat Res; 1996 Mar; 145(3):268-73. PubMed ID: 8927693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiobiological principles of the choice of dose fractionation in the radiotherapy of tumors].
    Akimov AA; Kozlov AP
    Med Radiol (Mosk); 1987 Jul; 32(7):81-6. PubMed ID: 3302586
    [No Abstract]   [Full Text] [Related]  

  • 33. Mean inactivation dose (D). A critical analysis of a neglected parameter in radiotherapy.
    Vijayakumar S; Ng TC; Raudkivi U; Meaney TJ
    Acta Oncol; 1990; 29(1):65-72. PubMed ID: 2178650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of whole brain radiotherapy combined with fractionated stereotactic radiotherapy in metastatic brain tumors, and prognostic factors.
    Kim HJ; Hong S; Kim S; Kim JH; Chie EK; Kim IH; Park CI; Ha SW; Wu HG; Kim DG; Kang WS
    Radiat Med; 2003; 21(4):155-60. PubMed ID: 14514121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How is it considered to advance radiotherapy from biological and clinical standpoint of view?].
    Sakamoto K
    Gan No Rinsho; 1990 Oct; 36(13):2387-92. PubMed ID: 2250361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Less well known parameters of in vitro radiosensitivity.
    Vijayakumar S; Ng TC; Koumoundouros I; Higgins PD; Thomas FJ
    J Natl Med Assoc; 1989 Jul; 81(7):799-802. PubMed ID: 2666680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of protracted low dose rate irradiation from an acute dose survival curve.
    Konishi K; Horiuchi J
    Cancer; 1978 Nov; 42(5):2211-5. PubMed ID: 719603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionated radiotherapy of tumour cells possessing wide-shouldered survival curves and capable of reoxygenation.
    McNally NJ
    Br J Radiol; 1980 Jul; 53(631):703-6. PubMed ID: 7426894
    [No Abstract]   [Full Text] [Related]  

  • 39. [The value of hyperfractionated irradiation from the viewpoint of radiobiological model findings].
    Kriester A; Kob D
    Radiobiol Radiother (Berl); 1989; 30(4):302-5. PubMed ID: 2798788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some implications of the Linear Quadratic model for tumor control probability.
    Yaes RJ
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):147-57. PubMed ID: 3335449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.